September 01, 2015

Accenture Helps Life Sciences Companies Improve Patient Support with Launch of the Accenture Intelligent Patient Platform

NEW YORK; Sept. 1, 2015 – Accenture (NYSE: ACN) is launching the Accenture Intelligent Patient Platform, a suite of integrated cloud-based, analytics-driven technologies designed to deliver real-time, actionable insights on patient care across the entire patient experience.

The Accenture Intelligent Patient Platform helps life sciences companies provide patients with comprehensive, outcome-driven patient services such as program enrollment, adherence management and treatment education over the full course of treatment for an illness or disease. It allows companies to rapidly deploy precise patient services based on the requirements of unique patient segments by providing an integrated set of capabilities across patient engagement and patient data management, including connected devices, apps and analytics.

The Accenture Intelligent Patient Platform is designed to evolve with the addition of new applications aimed at delivering supplementary services to meet patients’ changing needs. The new platform will enable life sciences companies to quantify the impact of their patient programs across all modes of engagement, such as in-person and digital, so they can refine program effectiveness and continuously improve the patient experience.

Intelligent Patient Platform video

The Accenture Intelligent Patient Platform provides several business benefits to life sciences companies, their customers, and their patients.

“The Accenture Intelligent Patient Platform is playing an important role helping life sciences companies deploy their patient engagement strategies and facilitate better patient interactions and outcomes,” said Tony Romito, managing director, Accenture Life Sciences. “Now companies can have real-time insight into the full patient journey and work across the healthcare system to effect meaningful change in support of the patient.”

“The Accenture Intelligent Patient Platform is the result of the close working relationship between Salesforce and Accenture,” said Kori O’Brien, vice president, global alliances and industry solutions, Salesforce. “We believe this Fullforce Solution will empower customers in the life sciences industry to connect with, care for and engage patients in meaningful new ways.”

The Accenture Intelligent Patient Platform, part of the Accenture Intelligent Patient Solutions and is comprised of an integrated set of evidence-based services supporting the full patient journey from pre-diagnosis through ongoing treatment to help life sciences clients deliver improved patient and economic outcomes. These services utilize unique population health analytics and proprietary patient technology to redefine how companies incorporate the patient into the development, launch and support of their innovative science. Click here to learn more about the Accenture Intelligent Patient Platform.

Salesforce Fullforce Solutions
Salesforce Fullforce Solutions are systems integrator or consulting partner offerings recognized for their specialization in priority Salesforce industries and other key solution areas. Fullforce Solution partners have demonstrated expertise and receive Salesforce go-to-market support, executive sponsorship and guidance as part of the Salesforce Partner Program.

Salesforce, Salesforce1, Fullforce and others are among the trademarks of, inc.

About Accenture
Accenture is a global management consulting, technology services and outsourcing company, with more than 336,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world’s most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$30.0 billion for the fiscal year ended Aug. 31, 2014. Its home page is

# # #


Cam Granstra
+ 1 312 693 5992